Selection of Ideal Reference Genes for Gene Expression Analysis in COVID-19 and Mucormycosis
ABSTRACT Selection of reference genes during real-time quantitative PCR (qRT-PCR) is critical to determine accurate and reliable mRNA expression. Nonetheless, not a single study has investigated the expression stability of candidate reference genes to determine their suitability as internal controls...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-12-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.01656-22 |
_version_ | 1798003867668971520 |
---|---|
author | Sunil Kumar Ayaan Ahmad Namrata Kushwaha Niti Shokeen Sheetal Negi Kamini Gautam Anup Singh Pavan Tiwari Rakesh Garg Richa Agarwal Anant Mohan Anjan Trikha Alok Thakar Vikram Saini |
author_facet | Sunil Kumar Ayaan Ahmad Namrata Kushwaha Niti Shokeen Sheetal Negi Kamini Gautam Anup Singh Pavan Tiwari Rakesh Garg Richa Agarwal Anant Mohan Anjan Trikha Alok Thakar Vikram Saini |
author_sort | Sunil Kumar |
collection | DOAJ |
description | ABSTRACT Selection of reference genes during real-time quantitative PCR (qRT-PCR) is critical to determine accurate and reliable mRNA expression. Nonetheless, not a single study has investigated the expression stability of candidate reference genes to determine their suitability as internal controls in SARS-CoV-2 infection or COVID-19-associated mucormycosis (CAM). Using qRT-PCR, we determined expression stability of the nine most commonly used housekeeping genes, namely, TATA-box binding protein (TBP), cyclophilin (CypA), β-2-microglobulin (B2M), 18S rRNA (18S), peroxisome proliferator-activated receptor gamma (PPARG) coactivator 1 alpha (PGC-1α), glucuronidase beta (GUSB), hypoxanthine phosphoribosyltransferase 1 (HPRT-1), β-ACTIN, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in patients with COVID-19 of various severities (asymptomatic, mild, moderate, and severe) and those with CAM. We used statistical algorithms (delta-CT [threshold cycle], NormFinder, BestKeeper, GeNorm, and RefFinder) to select the most appropriate reference gene and observed that clinical severity profoundly influences expression stability of reference genes. CypA demonstrated the most consistent expression irrespective of disease severity and emerged as the most suitable reference gene in COVID-19 and CAM. Incidentally, GAPDH, the most commonly used reference gene, showed the maximum variations in expression and emerged as the least suitable. Next, we determined expression of nuclear factor erythroid 2-related factor 2 (NRF2), interleukin-6 (IL-6), and IL-15 using CypA and GAPDH as internal controls and show that CypA-normalized expression matches well with the RNA sequencing-based expression of these genes. Further, IL-6 expression correlated well with the plasma levels of IL-6 and C-reactive protein, a marker of inflammation. In conclusion, GAPDH emerged as the least suitable and CypA as the most suitable reference gene in COVID-19 and CAM. The results highlight the expression variability of housekeeping genes due to disease severity and provide a strong rationale for identification of appropriate reference genes in other chronic conditions as well. IMPORTANCE Gene expression studies are critical to develop new diagnostics, therapeutics, and prognostic modalities. However, accurate determination of expression requires data normalization with a reference gene, whose expression does not vary across different disease stages. Misidentification of a reference gene can produce inaccurate results. Unfortunately, despite the global impact of COVID-19 and an urgent unmet need for better treatment, not a single study has investigated the expression stability of housekeeping genes across the disease spectrum to determine their suitability as internal controls. Our study identifies CypA and then TBP as the two most suitable reference genes for COVID-19 and CAM. Further, GAPDH, the most commonly used reference gene in COVID-19 studies, turned out to be the least suitable. This work fills an important gap in the field and promises to facilitate determination of an accurate expression of genes to catalyze development of novel molecular diagnostics and therapeutics for improved patient care. |
first_indexed | 2024-04-11T12:14:28Z |
format | Article |
id | doaj.art-ee4151c1be644922bc68e2a0c1d19099 |
institution | Directory Open Access Journal |
issn | 2165-0497 |
language | English |
last_indexed | 2024-04-11T12:14:28Z |
publishDate | 2022-12-01 |
publisher | American Society for Microbiology |
record_format | Article |
series | Microbiology Spectrum |
spelling | doaj.art-ee4151c1be644922bc68e2a0c1d190992022-12-22T04:24:26ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972022-12-0110610.1128/spectrum.01656-22Selection of Ideal Reference Genes for Gene Expression Analysis in COVID-19 and MucormycosisSunil Kumar0Ayaan Ahmad1Namrata Kushwaha2Niti Shokeen3Sheetal Negi4Kamini Gautam5Anup Singh6Pavan Tiwari7Rakesh Garg8Richa Agarwal9Anant Mohan10Anjan Trikha11Alok Thakar12Vikram Saini13Laboratory of Infection Biology and Translational Research, Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, IndiaLaboratory of Infection Biology and Translational Research, Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, IndiaLaboratory of Infection Biology and Translational Research, Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, IndiaLaboratory of Infection Biology and Translational Research, Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, IndiaLaboratory of Infection Biology and Translational Research, Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, IndiaLaboratory of Infection Biology and Translational Research, Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, IndiaDepartment of Otorhinolaryngology-Head & Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaDepartment of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaDepartment of Onco-Anesthesiology, Intensive Care, Pain and Palliative Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaDepartment of Onco-Anesthesiology, Intensive Care, Pain and Palliative Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaDepartment of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaDepartment of Onco-Anesthesiology, Intensive Care, Pain and Palliative Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaDepartment of Otorhinolaryngology-Head & Neck Surgery, All India Institute of Medical Sciences (AIIMS), New Delhi, IndiaLaboratory of Infection Biology and Translational Research, Department of Biotechnology, All India Institute of Medical Sciences, New Delhi, IndiaABSTRACT Selection of reference genes during real-time quantitative PCR (qRT-PCR) is critical to determine accurate and reliable mRNA expression. Nonetheless, not a single study has investigated the expression stability of candidate reference genes to determine their suitability as internal controls in SARS-CoV-2 infection or COVID-19-associated mucormycosis (CAM). Using qRT-PCR, we determined expression stability of the nine most commonly used housekeeping genes, namely, TATA-box binding protein (TBP), cyclophilin (CypA), β-2-microglobulin (B2M), 18S rRNA (18S), peroxisome proliferator-activated receptor gamma (PPARG) coactivator 1 alpha (PGC-1α), glucuronidase beta (GUSB), hypoxanthine phosphoribosyltransferase 1 (HPRT-1), β-ACTIN, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in patients with COVID-19 of various severities (asymptomatic, mild, moderate, and severe) and those with CAM. We used statistical algorithms (delta-CT [threshold cycle], NormFinder, BestKeeper, GeNorm, and RefFinder) to select the most appropriate reference gene and observed that clinical severity profoundly influences expression stability of reference genes. CypA demonstrated the most consistent expression irrespective of disease severity and emerged as the most suitable reference gene in COVID-19 and CAM. Incidentally, GAPDH, the most commonly used reference gene, showed the maximum variations in expression and emerged as the least suitable. Next, we determined expression of nuclear factor erythroid 2-related factor 2 (NRF2), interleukin-6 (IL-6), and IL-15 using CypA and GAPDH as internal controls and show that CypA-normalized expression matches well with the RNA sequencing-based expression of these genes. Further, IL-6 expression correlated well with the plasma levels of IL-6 and C-reactive protein, a marker of inflammation. In conclusion, GAPDH emerged as the least suitable and CypA as the most suitable reference gene in COVID-19 and CAM. The results highlight the expression variability of housekeeping genes due to disease severity and provide a strong rationale for identification of appropriate reference genes in other chronic conditions as well. IMPORTANCE Gene expression studies are critical to develop new diagnostics, therapeutics, and prognostic modalities. However, accurate determination of expression requires data normalization with a reference gene, whose expression does not vary across different disease stages. Misidentification of a reference gene can produce inaccurate results. Unfortunately, despite the global impact of COVID-19 and an urgent unmet need for better treatment, not a single study has investigated the expression stability of housekeeping genes across the disease spectrum to determine their suitability as internal controls. Our study identifies CypA and then TBP as the two most suitable reference genes for COVID-19 and CAM. Further, GAPDH, the most commonly used reference gene in COVID-19 studies, turned out to be the least suitable. This work fills an important gap in the field and promises to facilitate determination of an accurate expression of genes to catalyze development of novel molecular diagnostics and therapeutics for improved patient care.https://journals.asm.org/doi/10.1128/spectrum.01656-22gene expressionqRT-PCRreference geneSARS-CoV-2COVID-19mucormycosis |
spellingShingle | Sunil Kumar Ayaan Ahmad Namrata Kushwaha Niti Shokeen Sheetal Negi Kamini Gautam Anup Singh Pavan Tiwari Rakesh Garg Richa Agarwal Anant Mohan Anjan Trikha Alok Thakar Vikram Saini Selection of Ideal Reference Genes for Gene Expression Analysis in COVID-19 and Mucormycosis Microbiology Spectrum gene expression qRT-PCR reference gene SARS-CoV-2 COVID-19 mucormycosis |
title | Selection of Ideal Reference Genes for Gene Expression Analysis in COVID-19 and Mucormycosis |
title_full | Selection of Ideal Reference Genes for Gene Expression Analysis in COVID-19 and Mucormycosis |
title_fullStr | Selection of Ideal Reference Genes for Gene Expression Analysis in COVID-19 and Mucormycosis |
title_full_unstemmed | Selection of Ideal Reference Genes for Gene Expression Analysis in COVID-19 and Mucormycosis |
title_short | Selection of Ideal Reference Genes for Gene Expression Analysis in COVID-19 and Mucormycosis |
title_sort | selection of ideal reference genes for gene expression analysis in covid 19 and mucormycosis |
topic | gene expression qRT-PCR reference gene SARS-CoV-2 COVID-19 mucormycosis |
url | https://journals.asm.org/doi/10.1128/spectrum.01656-22 |
work_keys_str_mv | AT sunilkumar selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT ayaanahmad selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT namratakushwaha selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT nitishokeen selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT sheetalnegi selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT kaminigautam selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT anupsingh selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT pavantiwari selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT rakeshgarg selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT richaagarwal selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT anantmohan selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT anjantrikha selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT alokthakar selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis AT vikramsaini selectionofidealreferencegenesforgeneexpressionanalysisincovid19andmucormycosis |